FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Akorn Eptifibatide Injection Recall

Eptifibatide Injection, a) 20 mg/10 mL (2 mg/mL),10 mL Single Use Vial

Akorn, Inc. · Lake Forest, IL

Risk level
Class III
Reported by FDA
Sep 4, 2019
Recall ID
D-1841-2019
Check your lot numberHow we source this data

Summary

Akorn recalled Eptifibatide Injection starting Aug 6, 2019. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1841-2019 on Sep 4, 2019. Reason: Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.

Product description

Eptifibatide Injection, a) 20 mg/10 mL (2 mg/mL),10 mL Single Use Vial, NDC 17478-902-10, b) 200 mg/100 mL (2 mg/mL), 100 mL Single-use Vial, NDC 17478-902-90, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045.

Lot numbers, UPCs & expiration codes

Lot #s: a) 091307A, Exp. 9/19; 101097A, Exp. 10/19; b) 091277A, Exp. 9/19.

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1841-2019
Classification
Class III
Status
Terminated
Recall initiated
Aug 6, 2019
FDA report date
Sep 4, 2019
Quantity
8187 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Akorn, Inc.

Original FDA data

Every field from FDA enforcement report D-1841-2019, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
83497
Address
1925 W Field Ct Ste 300
Code information
Lot #s: a) 091307A, Exp. 9/19; 101097A, Exp. 10/19; b) 091277A, Exp. 9/19.
Postal code
60045-4862
Report date
Sep 4, 2019
Product type
Drugs
Recall number
D-1841-2019
Classification
Class III
Recalling firm
Akorn, Inc.
Product quantity
8187 vials
Termination date
Jul 28, 2022
Reason for recall
Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Eptifibatide Injection, a) 20 mg/10 mL (2 mg/mL),10 mL Single Use Vial, NDC 17478-902-10, b) 200 mg/100 mL (2 mg/mL), 100 mL Single-use Vial, NDC 17478-902-90, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Aug 6, 2019
Initial firm notification
Letter
Center classification date
Aug 23, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1841-2019, published Sep 4, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls